World
CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
AIDS Vaccine Advocacy Coalition calls for Viread trials to continue
Although worldwide clinical trials of the anti-HIV drug Viread are drawing criticism from AIDS activists, the AIDS Vaccine Advocacy Coalition on Thursday issued a report that calls for the studies to continue, as the drug is still a possible way to prevent HIV infections. The report, titled "Will a Pill a Day Prevent HIV? Anticipating the Results of the Tenofovir PREP Trials," examines the issues and ethical concerns raised by some activists, particularly whether sex workers and injection-drug users in developing countries participating in the trials are being adequately counseled on safer sex, and whether those who become infected during the study should be given free lifetime supplies of antiretroviral drugs. AVAC says these issues can be adequately addressed by trial organizers and funders, and that the studies should continue with more concerted coordination and advance planning to accelerate data evaluation.
"The concerns raised about the trials are serious, and there is a need for thorough and unbiased investigation," said Mitchell Warren, AVAC executive director, in a press statement. "But all of the concerns raised are solvable. AVAC calls on researchers, communities, and advocates to work together to ensure that ethical concerns are addressed, solutions are found, and the trials go forward."
The studies, under way among sexually active gay men in the United States, female sex workers in Africa, and injection-drug users in Thailand, aim to determine whether daily doses of Viread are effective in preventing HIV infections that are transmitted through sexual contact or needle sharing. The AVAC report says that the World Health Organization, the Joint United Nations Programme on HIV/AIDS, the trial sponsors, and other organizations should work together to ensure that research and trials are coordinated and progress in an accelerated fashion--and that additional research is carried out in an expedited fashion--to ensure that it is known as soon as possible if Viread is a safe and effective HIV prevention intervention.
"We need as many HIV prevention tools as possible, so research on vaccines, microbicides, and other potential interventions must also be accelerated whether or not Viread proves appropriate for preexposure prophylaxis," Warren said.
The AVAC report is available online at www.avac.org and in print by sending a request via e-mail to avac@avac.org.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Here Are Our 2024 Election Predictions. Will They Come True?
November 07 2023 1:46 PM
Meet all 37 of the queer women in this season's WNBA
April 17 2024 11:24 AM
17 Celebs Who Are Out & Proud of Their Trans & Nonbinary Kids
November 30 2023 10:41 AM
Here Are the 15 Most LGBTQ-Friendly Cities in the U.S.
November 01 2023 5:09 PM
Which State Is the Queerest? These Are the States With the Most LGBTQ+ People
December 11 2023 10:00 AM
These 27 Senate Hearing Room Gay Sex Jokes Are Truly Exquisite
December 17 2023 3:33 PM
10 Cheeky and Homoerotic Photos From Bob Mizer's Nude Films
November 18 2023 10:05 PM
42 Flaming Hot Photos From 2024's Australian Firefighters Calendar
November 10 2023 6:08 PM
These Are the 5 States With the Smallest Percentage of LGBTQ+ People
December 13 2023 9:15 AM
Here are the 15 gayest travel destinations in the world: report
March 26 2024 9:23 AM
Watch Now: Advocate Channel
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Latest Stories
The Tip Off: A beginners guide to the WNBA
April 20 2024 11:06 AM
John Fetterman challenges Pa. school board’s cancellation of talk by gay actor
April 19 2024 2:39 PM
New study finds inadequate response to mpox outbreak
April 19 2024 2:06 PM
Fighting back against MAGA’s attacks on equality
April 19 2024 1:00 PM
Just one Christian Nationalist group is behind Idaho's bans on trans care and abortion
April 19 2024 11:57 AM
Linda Perry opens up in new documentary, premiering in June at Tribeca Festival
April 19 2024 11:43 AM
Trans woman loses lower legs in NYC subway attack. Now, friends rally to help her
April 19 2024 10:06 AM
Black trans woman África Parrilla García shot to death in Puerto Rico
April 18 2024 4:55 PM
Marjorie Taylor Greene has sunk so low even Fox News can't stand her anymore
April 18 2024 4:04 PM
Single lesbians are avoided by straight women, but not straight men. Here's why.
April 18 2024 3:18 PM
The LGBTQ+ movie fan's guide to the 2024 TCM Classic Film Festival
April 18 2024 2:44 PM
The federal government failed on mpox. Ritchie Torres's new bill addresses that (exclusive)
April 18 2024 1:21 PM
True
In the face of tweets and turmoil, why I left the South as a medical student
April 18 2024 7:30 AM